Gabriel Levin
Gabriel Levin is an expert in Gynecology at Hadassah Medical Center (Israel). As of October 2026, ScienceLeadR ranks Gabriel Levin in the top 1% of experts worldwide for Pregnancy Complications and Epidemiologic Studies, and in the top 1% of experts in Israel for Urogenital Neoplasms. Gabriel Levin has authored 456 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 1,548 (community average: 125). How the SLR is computed.
LeadR Profile
Gynecology
Subspecialties: Obstetrics - Oncology - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 456
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions. PMID 42677467 — obstetrics, squamous intraepithelial lesions, uterine cervical dysplasia, research, therapeutics, alphapapillomavirus, wounds and injuries, papillomavirus infections, infections, human papillomavirus viruses | Int J Gynaecol Obstet | 2026 | 0 |
| Partial posterior uterine rupture in a non-scarred term uterus associated with the presence of endometriosis. PMID 42462568 — endometriosis, reproduction, uterus, obstetrics, gynecology, rupture, uterine rupture | Eur J Obstet Gynecol Reprod Biol | 2026 | 0 |
| Para-Aortic Lymph Node Staging and Oncologic Outcomes in Locally Advanced Cervical Cancer: A Narrative Review. PMID 42449603 — radiotherapy, lymph nodes, lymph node excision, uterine cervical neoplasms, neoplasms, neoplasm staging, diagnostic imaging, chemoradiotherapy, lymph, therapeutics | Cancers (Basel) | 2026 | 1 |
| The Impact of Pathogenic Variants of BRCA1, BRCA2 and Other DNA-Repair Genes on the Survival Benefits Conferred by PARP Inhibitors - Single Center Experience from Quebec. PMID 42398909 — genes, dna repair, poly(adp-ribose) polymerase inhibitors, ovary, neoplasms, maintenance, ovarian neoplasms, therapeutics, genes, brca2, genes, brca1, dna | J Obstet Gynaecol Can | 2026 | 0 |
| Robotic vs laparoscopic interval cytoreductive surgery in stage III ovarian cancer: an analysis of the National Cancer Database. PMID 42302709 — cytoreduction surgical procedures, ovary, genital neoplasms, female, neoplasms, ovarian neoplasms | Int J Gynecol Cancer | 2026 | 3 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map